Ep 5. Steven Hoffman & international law; heteroresistance; AMR funding.
2019-03-04
Join us this time to learn about the journey of Professor Steven Hoffman, a lawyer specialized in international law working on AMR. In the news sections we will be talking about heteroresistance, a quite sneaky type of resistance; and about a dialogue paper dwelling on the global AMR financing situation.
You can follow us and subscribe to our podcast to get new episodes directly in your preferred device and platform:
or you can listen to our fifth episode right here:
Relevant links:
- The Global Strategy Lab: bi-campus interdisciplinary research program based at York University and the University of Ottawa focusing on addressing transnational health threats and social inequalities.
- The Dag Hammarskjöld Foundation: non-governmental organisation which aims to advance dialogue and policy for sustainable development and peace.
Further Reading:
- Special Issue Symposium on Antimicrobial Resistance. Journal of Law, Medicine & Ethics. Special issue containing pieces S. Hoffman & some others already interviewed in our podcast.
- Economic incentives for the development of new antibiotics. Report commisioned by the Publich Health Agency of Sweden and conducted by researchers at Uppsala University.
- Effectiveness of interventions to improve the public’s antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review. Review article about public awarness.
- The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Scientific article referred in the first news item.
- Frequency of heteroresistance has been greatly underestimated, study finds. Press coverage of the heteroresistance article.
- Antimicrobial Resistance and Sustainable Development: A Planetary Threat but a Financing Orphan. Dialog paper on the current AMR financing situation.
- Groups Urge Congress to Act on Antibiotic Resistance. Call from Pew and 25 other organizations call for incentives to spur new drug development.
If you have any comments and suggestions you can email us here, or tweet to us (@UAC_UU) using the hashtag #theAMRStudio.